BASAPPA, N. S. Treatment options in advanced renal cell carcinoma after first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitors. Canadian Urological Association Journal, [S. l.], v. 10, n. 11-12, p. S242–4, 2016. DOI: 10.5489/cuaj.4292. Disponível em: https://cuaj.ca/index.php/journal/article/view/4292. Acesso em: 29 mar. 2024.